Beckman Coulter can stand "toe to toe" with rivals
This article was originally published in Clinica
Executive Summary
Beckman Coulter "now has enough size to stand toe-to-toe with anybody" among the major diagnostic instrument manufacturers, says Jay Steffenhagen, the company's vice-president for corporate strategic planning and business development. He was recounting the strategic value of the five acquisitions made by the company during 1996 and 1997 at the recent UBS Warburg Global Life Sciences conference in New York.